Nanobiotix, a Paris-headquartered clinical-stage nanomedicine company, has opened its first U.S. office in Boston.
This move is the next step of Nanobiotix’s international expansion, allowing the company to work closer to the U.S. industrial and financial communities, to benefit the company’s potential future development beyond NanoXray.
To lead the development of the U.S. affiliate, Patrick Tricoli has been appointed vice president, corporate development. Tricoli has over 25 years’ experience within the pharmaceutical industry and joins Nanobiotix from Sanofi, where he held a number of positions in both corporate and R&D. In recent years, Tricoli has focused on international business development and partnering activities.